Theranostic outpatient clinic

Home - Minute Medical

Patients' Testimonials

Can ¹⁷⁷Lu-PSMA damage the kidneys? | MINUTE medical

PSMA Upregulation on Enzalutamide: ENZA-p | MINUTE medical

BULLSEYE Trial: Lu-PSMA Therapy Delays Hormone Therapy in Oligometastatic Hormone-Sensitive Prostate Cancer | MINUTE Medical

From Blind Biopsy to Imaging-First: How PSMA Imaging Is Moving Upstream into the Initial Diagnostic Phase - Minute Medical

Common Mistakes in Performing & Interpreting PSMA PET/CT Scans - Minute Medical

Clinical Case: Personalized Theranostics in Occult Peritoneal Carcinomatosis

PSMA Radioligand Therapy Is Moving Earlier in the Prostate Cancer Treatment Sequence - Minute Medical

PSMAddition: Adding ¹⁷⁷Lu-PSMA to Standard Treatment at the Hormone-Sensitive Stage of Prostate Cancer Proves Beneficial - Minute Medical

¹⁶¹Terbium-PSMA Radioligand Therapy in Prostate Cancer Brain Metastases - Minute Medical

Upregulating PSMA: How Antihormonal Therapy Assists Radioligand Therapy - Minute Medical

Therapy Response After Combined CyberKnife & PSMA Radioligand Therapy - Minute Medical

Compatibility of CyberKnife and PSMA Radioligand Therapy in Treating Prostate Cancer - Minute Medical

"At the forefront of medicine, with outstanding human care" - Minute Medical

Interview with Prof. Haug, conducted by Primo Medico on 09 July 2025 - Minute Medical

Interview with Prof. Hartenbach about PSMA radioligand therapy

What if my oncologist doesn’t recommend ¹⁷⁷Lu-PSMA? - Minute Medical

Minute Medical Theranostics Center of Excellence

UpFrontPSMA Trial Results: PSMA Therapy Advances to the Frontlines of Prostate Cancer Treatment - Minute Medical

WARMTH Act: ²²⁵Ac-PSMA in treating metastatic castration-resistant prostate cancer - Minute Medical